LESS-EProspective Randomized Comparison of Single-port and Four-port Laparoscopic Staging Operation for Endometrial Cancer
single-port laparoscopic surgical staging
+ Four-port laparoscopic surgical staging
Urogenital Diseases+9
+ Genital Diseases
+ Female Urogenital Diseases and Pregnancy Complications
Treatment Study
Summary
Study start date: January 1, 2013
Actual date on which the first participant was enrolled.To compare the feasibility, safety, and efficacy between single-port and four-port laparoscopic surgical staging in patients with early stage endometrial cancer.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.107 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Female
Biological sex of participants that are eligible to enroll.Over 20 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion Criteria: Previously untreated, histologically confirmed endometrial cancer Presumed FIGO stage 1 Endometrioid adenocarcinoma patient who is planned to undergo surgical staging adequate oran function WBC > 3000 cells/mcl Platelets > 100000/mcl Creatinine < 2.0 mg/dL Bilirubin < 1.5 * normal and SGOT or SGPT < 3 * normal American Society of Anesthesiologists Physical Status I-II Eastern Cooperative Oncology Group performance status 0-2 Patients who have signed an approved Informed Consent Exclusion Criteria: Uncontrolled medical disease Active infectious disease requiring antibiotics Previous pelvic radiation therapy Pregnant and lactating woman Patient who requires additional surgical procedures which are not necessary for surgical staging of endometrial cancer
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
Active ComparatorStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center
Seoul, South KoreaOpen Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center in Google Maps